Starling Oncology, Inc.

STLN
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0001799191

Other share classesDFPHSTLNW

Price chart

Open-market purchases and sales by STLN insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 24, 20265:11 PM ETAug 21, 2026Hively BradDirectorSSaleCommon Stock−298.85K$6.5126−$1.95M411.98K−42.0%SEC10b5-1
Aug 17, 202610:13 AM ETAug 14, 2026Chernett Jorey10% OwnerPPurchaseCommon Stock+12K$6.54+$78.48K10.66M+0.1%SEC
Aug 17, 202610:13 AM ETAug 13, 2026Chernett Jorey10% OwnerSSaleCommon Stock · Derivative−10K$0.0624−$6240–SEC
Jul 22, 20269:55 AM ETJul 21, 2026Chernett Jorey10% OwnerPPurchaseCommon Stock+18K$5.27+$94.86K10.65M+0.2%SEC
Jul 16, 20268:05 PM ETJul 14, 2026Podnos YaleChief Medical OfficerSSaleCommon Stock−23.45K$6.4105−$150.34K259.53K−8.3%SEC10b5-1

The largest institutional positions in STLN at the end of Q2 2026.

Institutions holding STLN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.4,749,030$25.79M0.00%+333,163+7.5%Added
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)3,360,052$18.25M0.19%00.0%Unchanged
VANGUARD CAPITAL MANAGEMENT LLC3,265,531$17.73M0.00%−211,250−6.1%Reduced
JOSH ARNOLD INVESTMENT CONSULTANT, LLC2,464,359$13.38M8.42%00.0%Unchanged
GEODE CAPITAL MANAGEMENT, LLC1,899,998$10.32M0.00%+142,151+8.1%Added